Disney Layoffs Hit TV Development & Casting Executive Ranks
Names of Disney TV executives impacted by today's sweeping layoffs are starting to emerge. As Deadline reported exclusively earlier today, several hundred employees are being laid off globally, with Disney Entertainment's film and television marketing as well as television publicity, casting and development, among the main targets.
According to sources, leaving is Eric Souliere, VP Casting for 20th Television who had been working on Ryan Murphy's American Horror Story and 9-1-1 series. He is not going far though as the former casting director will be transitioning to casting on the new 9-1-1 spinoff, Nashville, I hear.
More from Deadline
Ex-'Doctor Odyssey' Crew Members Sue Disney, 20th TV Claiming Sexual Harassment And Wrongful Termination
Marvel Skipping Comic-Con's Hall H This Year
'Lilo & Stitch': All The Box Office Records Broken
Also said to be departing is Tony Tompson, VP Content Development at Hulu Originals who had been at the streamer for more than six years. He already is pursuing new opportunities and has been meeting for jobs. Lower level development executives, including a manager of drama programming, ABC Hulu, also have been affected.
There has been some confusion today as several Disney TV executives are leaving or have just left though their exits are not part of today's layoffs.
That includes SVP Casting Dylann Brander Gunning who departed after her contract was up last month, I hear. She was head of casting at ABC Signature before the casting departments of 20th TV and ABC Signature were merged in August under 20th TV Head of Casting Stephanie Levinson, with Gunning reporting to her.
Also no longer part of Disney is Crystal Holt, VP Series for 20th TV, as well as Collin Sapera, VP Drama Development, ABC Hulu, whose contract was up. Other recent Disney departures include Ashley Chang who left as Hulu VP Content Development to join Amazon MGM Studios.
Best of Deadline
Everything We Know About 'Stranger Things' Season 5 So Far
2025 TV Series Renewals: Photo Gallery
2025 TV Cancellations: Photo Gallery
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
30 minutes ago
- Forbes
Rachel Zegler's ‘Snow White' Gets Disney+ Streaming Date
"Snow White" partial poster featuring Rachel Zegler. Snow White — Rachel Zegler and Gal Gadot's beleaguered live-action adaptation of Snow White and the Seven Dwarfs — is coming soon to Disney+. Directed by Marc Webb, Snow White opened in theaters on March 21 and debuted on digital streaming on May 13. The official synopsis for the movie reads, 'Disney's Snow White is a vibrant live-action musical reimagining of Walt Disney's groundbreaking full-length animated classic. 'Experience the timeless adventure as Snow White (Zegler) journeys into magical woods to escape her stepmother, the Evil Queen (Gadot), and meets the beloved Bashful, Sleepy, Sneezy, Happy, Dopey, Grumpy and Doc who join her quest to restore the kingdom and bring kindness to the land.' Walt Disney Home Entertainment announced on Wednesday that Snow White will premiere on streaming video on demand on Disney+ on Wednesday, June 11. You must be a Disney+ subscriber to watch Snow White on the platform. The platform offers an ad-based Disney+ Basic plan for $9.99 per month, as well as an ad-free Disney+ Premium plan for $15.99 per month or $159.99 per year. Disney+ is also available in bundling packages with fellow streaming services Hulu and Max. Snow White had a rough run in theaters following a slew of pre-release controversies, including Rachel Zegler's criticism of the 1937 animated classic Snow White and the Seven Dwarfs and politically divisive social media posts, and Disney's handling of how the seven dwarfs should be represented on screen. Disney ultimately settled on CGI dwarfs to represent the diminutive characters. Snow White, which is still in theaters, has to date earned $87.2 million in North American theaters and $118.3 million internationally for a worldwide box office tally of $205.5 million worldwide against a $269.4 million production budget before prints and advertising, according to The Numbers. The film earned a 40% 'rotten' rating from Rotten Tomatoes critics based on 258 reviews. The Critics Consensus on the review aggregation site reads, 'Snow White is hardly a grumpy time at the movies thanks to Rachel Zegler's luminous star turn, but its bashful treatment of the source material along with some dopey stylistic choices won't make everyone happy, either.' Snow White, however, did receive a 71% 'fresh' score on RT's Popcornmeter based on 2,500-plus verified user ratings. Snow White will arrive on Disney+ on June 11.


Indianapolis Star
30 minutes ago
- Indianapolis Star
Disney reveals when 'Snow White' remake is coming to streaming
The live-action remake of "Snow White" will make its streaming debut next week, Disney announced Wednesday, June 4. The adaptation starring Rachel Zegler as the titular princess hit theaters on March 21 and has since grossed more than $205 million worldwide, according to Box Office Mojo. The film adapts the 1937 animated classic "Snow White and the Seven Dwarfs," Walt Disney Animation Studios first full-length feature that went on to be nominated for the Best Picture Academy-Award and won an honorary Oscar. In addition to Zegler, the new remake also features "Wonder Woman" star Gal Gadot as the Evil Queen as well as Andrew Burnap as love interest Jonathan and Martin Klebba as Grumpy the dwarf. The streaming announcement comes as Disney continues to reimagine some of its most beloved movies from 2019's "The Lion King" to 2023's "The Little Mermaid." Disney's 2025 live-action "Snow White" film will be available to stream on Wednesday, June 11.
Yahoo
34 minutes ago
- Yahoo
Cepheid Receives Health Canada Licence for Xpert® HIV-1 Viral Load XC
Next-Generation Molecular Test for Monitoring Viral Load and HIV-1 Infection SUNNYVALE, Calif., June 4, 2025 /CNW/ -- Cepheid today announced that Health Canada has issued Cepheid a medical device licence for Xpert® HIV-1 Viral Load XC, a next-generation extended-coverage (XC) test intended to aid in assessing HIV viral load levels, which are used to monitor effectiveness of antiretroviral treatment. Xpert® HIV-1 Viral Load XC dual target test provides extended strain coverage ensuring a high level of performance with a simple workflow to improve patient access to the standard of care and help achieve UNAIDS HIV targets by 2030.1 "Xpert® HIV-1 Viral Load XC leverages dual target technology to improve detection while maintaining the flexibility to be performed on-demand in as little as 90 minutes." said Vitor Rocha, President of Cepheid. "Access to the test can enhance patient care, as measurement of HIV viral load informs treatment plans while fast results enable earlier interventions with counseling and therapy." The test is designed for use on any of Cepheid's GeneXpert® Systems which provide simple, reference lab quality PCR testing on location in laboratory environments at medical centers and hospitals or in community health clinics and physician offices. Xpert® HIV-1 Viral Load XC will begin shipping to customers in Canada in June 2025. Visit for more information. Malisa et al 2023 Nature Scientifc Reports | (2023) 13:4578https:// About CepheidBased in Sunnyvale, Calif., Cepheid is a leading molecular diagnostics company that is an operating company within Danaher Corporation's Diagnostics platform. Cepheid is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit IVD. In Vitro Diagnostic Medical Device. May not be available in all countries For Cepheid Media Inquiries:Darwa SOURCE Cepheid View original content to download multimedia: Erreur lors de la récupération des données Connectez-vous pour accéder à votre portefeuille Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données